{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T18:20:31Z","timestamp":1773685231369,"version":"3.50.1"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011447","name":"Science and Technology Department of Henan Province","doi-asserted-by":"crossref","award":["LHGJ20190039"],"award-info":[{"award-number":["LHGJ20190039"]}],"id":[{"id":"10.13039\/501100011447","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011447","name":"Science and Technology Department of Henan Province","doi-asserted-by":"crossref","award":["SBGJ20202076"],"award-info":[{"award-number":["SBGJ20202076"]}],"id":[{"id":"10.13039\/501100011447","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["U1804192"],"award-info":[{"award-number":["U1804192"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>B-lymphoblastic lymphoma (B-LBL) with BCR\/ABL mutation (Ph+ B-LBL) is a rare type of cancer in both childhood and adults. Its clinical manifestations are similar to those of other types lymphoma. However, the targeted therapy can substantially improve the outcome of Ph+ B-LBL.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 19-year-old male with blood type O, Rh+ was admitted into our hospital on August 14, 2018, due to a recurrent fever and hypocytosis for 6\u200amonths.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Routine blood exam showed pancytopenia. Bone marrow sample flow cytometry (FCM) exam showed abnormal cells were 2.27% of the nucleated cells, and was classified as the abnormal early B-lineage lymphoblastic cells. FISH testing showed the BCR\/ABL positive cells were 13.6%. Karyotype analysis showed the 46, XY, t(9;22)(q34;q11). Molecular analysis of BCR\/ABL mutation on ABL kinase showed that BCR\/ABL T315I mutation. Patient was diagnosed with B-LBL with BCR\/ABL mutation (Ph+ B-LBL).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient was given chemotherapy with VDPI regimen (Vinorelbine, daunorubicin, prednisone, imatinib).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient achieved complete remission after 2 courses\u2019 treatment, followed by one course of clarithromycin regimen and another two courses of VDPI regimen. Patient remains in complete remission as of March 10, 2021.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>In B-LBL, a BCR\/ABL mutation can happen in some of these patients. It is important to guide the pathologist to perform appropriate gene mutation detection, in addition to routine Immunohistochemistry test, to ensure an accurate diagnosis and use the targeted agent for treatment. According to the literature and our results, it seems that intensive chemotherapy plus TKI regimen is effective in inducing complete remission, and allo-SCT should be used as a long-term strategy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000026323","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T15:00:10Z","timestamp":1623423610000},"page":"e26323","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Philadelphia chromosome-positive B-lymphoblastic lymphoma successfully treated with chemotherapy regimen containing imatinib"],"prefix":"10.1097","volume":"100","author":[{"given":"Xiaoning","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongxing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingming","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1217-4385","authenticated-orcid":false,"given":"Jifeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.critrevonc.2017.03.020","article-title":"Lymphoblastic lymphoma","volume":"113","author":"Cortelazzo","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1080\/10428194.2019.1706736","article-title":"BCR-ABL1 positive lymphoblastic lymphoma - should it be treated like a B-lymphoblastic leukemia with t(9;22);BCR-ABL1?","volume":"61","author":"Takahashi","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.3109\/10428194.2012.760735","article-title":"Philadelphia chromosome positive B-cell lymphoblastic lymphoma isolated to bone","volume":"54","author":"Sadrzadeh","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1080\/15384047.2015.1056412","article-title":"Primary testicular Ph-positive B lymphoblastic lymphoma: an unusual presentation and review","volume":"16","author":"Zhu","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"R5-20250504","first-page":"2413587","article-title":"An unsuspected finding of t(9;22): a rare case of Philadelphia chromosome-positive B-Lymphoblastic lymphoma","volume":"2017","author":"Boddu","year":"2017","journal-title":"Case Rep Hematol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.hemonc.2018.05.007","article-title":"Philadelphia chromosome-positive lymphoblastic lymphoma-Is it rare or underdiagnosed?","volume":"13","author":"Alshomar","year":"2020","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"R7-20250504","first-page":"10","article-title":"BCR\/ABL1-positive B-lymphoblastic Lymphoma Successfully Treated with Dasatinib-combined Chemotherapy","volume":"2","author":"Yamada","year":"2021","journal-title":"Intern Med (Tokyo, Japan)"},{"key":"R8-20250504","first-page":"15","article-title":"Precursor B-cell lymphoblastic lymphoma (PBLL) in children: pattern of presentation and outcome","volume":"17","author":"Belgaumi","year":"2005","journal-title":"J Egypt Natl Canc Inst"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/j.clml.2014.01.004","article-title":"Extramedullary B lymphoblastic leukemia\/lymphoma (B-ALL\/B-LBL): a diagnostic challenge","author":"Geethakumari","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk V 14"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/PAI.0b013e31825d550a","article-title":"Selective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results","volume":"21","author":"Boyd","year":"2013","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"02","DOI":"10.1186\/s40164-019-0158-5","article-title":"Gene mutational analysis by NGS and its clinical significance in patients with myelodysplastic syndrome and acute myeloid leukemia","volume":"9","author":"Yu","year":"2020","journal-title":"Exp Hematol Oncol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1182\/blood-2016-03-707562","article-title":"Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"128","author":"Short","year":"2016","journal-title":"Blood"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026323","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:33:58Z","timestamp":1746336838000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026323"}},"subtitle":["A rare case report and literature review"],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":12,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000026323","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,11]]},"assertion":[{"value":"2021-03-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}